Laserfiche WebLink
57, Agrees to comply with the Drug ork -Free B <br />place Act of 1988, and certifies that it will <br />• or will continue to provide a drug-free workplace by: <br />a. Publishing a statement notifying employees that the unlawful manufacture, <br />distribution, dispensing, possession, or use of a controlled substance is prohibited <br />in the grantee's workplace and specifying the actions that will be taken against <br />employees for violation of such prohibition. <br />b. Establishing an ongoing drug-free awareness program to inform employees <br />about: <br />i. The dangers of drug abuse in the workplace; <br />ii. The grantee's policy of maintaining a drug-free workplace; <br />iii, Any available drug counseling, rehabilitation, and employee assistance <br />programs; and <br />iv. The penalties that may be imposed upon employees for drug abuse violations <br />occurring in the workplace. <br />c. Making it a requirement that each employee engaged in the performance of the <br />grant be given a copy of the statement required by paragraph (a). <br />d. Notifying the employee in the statement required by paragraph (a) that, as a <br />condition of employment under the grant, the employee will: <br />i. Abide by the terms of the statement; and <br />ii. Notify the employer in writing of his or her conviction for a violation of <br />a criminal drug statute occurring in the workplace no later than five <br />calendar days after such conviction. <br />e. Notifying Cal EMA, in writing, within 10 calendar days after receiving notice <br />under subparagraph (d)(ii) from an employee or otherwise receiving actual notice <br />of such conviction. Employers of convicted employees must provide notice, <br />including position title, to: <br />• Department of Justice, Office of Justice Programs <br />ATTN: Control Desk <br />633 Indiana Avenue, N.W. <br />Washington, DC 20531 <br />Notice shall include the identification number(s) of each affected grant. <br />f. Taking one of the following actions, within 30 calendar days of receiving notice <br />under subparagraph (d)(ii), with respect to any employee who is so convicted. <br />L Taking appropriate personnel action against such an employee, up to and <br />including termination, consistent with the requirements of the <br />Rehabilitation Act of 1973, as amended; or <br />ii. Requiring such employee to participate satisfactorily in a drug abuse <br />assistance or rehabilitation program approved for such purposes by a <br />federal, state, or local health, law enforcement, or other appropriate <br />agency. <br />g. Making a good faith effort to continue to maintain a drug-free workplace <br />through implementation of paragraph 57 subsections (a), (b), (c), (d), (e), and (f). <br />58. Will comply with all applicable requirements of all other federal and state laws, EOs, <br />regulations, program and administrative requirements, policies and any other requirements <br />governing this program. <br />59. Understands the reporting of subawards and executive compensation rules, including <br />first tier subawards to Cal EMA. <br />a. Applicability: unless you are exempt as provided in subsection (d) of this <br />paragraph, subrecipient must report each action that obligates $25,000 or more in <br />• Federal funds that does not include Recovery funds (as defined in section <br />1512(a)(2) of the American Recovery and Reinvestment Act of 2009. <br />b. Where and when to report: you must report each obligating action described in <br />the following paragraphs to Cal EMA. For subaward information, report no later <br />38